CA2214533C - Quinolyloxazole-2-ones utiles comme inhibiteurs de la proteinekinase c - Google Patents

Quinolyloxazole-2-ones utiles comme inhibiteurs de la proteinekinase c Download PDF

Info

Publication number
CA2214533C
CA2214533C CA002214533A CA2214533A CA2214533C CA 2214533 C CA2214533 C CA 2214533C CA 002214533 A CA002214533 A CA 002214533A CA 2214533 A CA2214533 A CA 2214533A CA 2214533 C CA2214533 C CA 2214533C
Authority
CA
Canada
Prior art keywords
compound
alkyl
formula
quinolinyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002214533A
Other languages
English (en)
Other versions
CA2214533A1 (fr
Inventor
Winton Dennis Jones
Richard Cyrus Dage
George Philip Claxton
Hsien Chang Cheng
Phillip James Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/261,435 external-priority patent/US4886811A/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of CA2214533A1 publication Critical patent/CA2214533A1/fr
Application granted granted Critical
Publication of CA2214533C publication Critical patent/CA2214533C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention porte sur de nouvelles quinolyloxazole-2-ones de formule:
CA002214533A 1988-10-24 1989-10-16 Quinolyloxazole-2-ones utiles comme inhibiteurs de la proteinekinase c Expired - Fee Related CA2214533C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US261,435 1988-10-24
US07/261,435 US4886811A (en) 1988-10-24 1988-10-24 Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
CA002000804A CA2000804C (fr) 1988-10-24 1989-10-16 Quinolyloxazoles-2-ones utiles comme inhibiteurs de la proteinekinase c

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002000804A Division CA2000804C (fr) 1988-10-24 1989-10-16 Quinolyloxazoles-2-ones utiles comme inhibiteurs de la proteinekinase c

Publications (2)

Publication Number Publication Date
CA2214533A1 CA2214533A1 (fr) 1990-04-24
CA2214533C true CA2214533C (fr) 2001-06-05

Family

ID=25673763

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002214533A Expired - Fee Related CA2214533C (fr) 1988-10-24 1989-10-16 Quinolyloxazole-2-ones utiles comme inhibiteurs de la proteinekinase c

Country Status (1)

Country Link
CA (1) CA2214533C (fr)

Also Published As

Publication number Publication date
CA2214533A1 (fr) 1990-04-24

Similar Documents

Publication Publication Date Title
US4886811A (en) Qunolyloxazole-2-ones useful as proteinkinase C inhibitors
CN110352188B (zh) 氟代烯丙胺衍生物及其用途
JP2022050469A (ja) リガンド依存性の標的タンパク質分解のための単官能性中間体
RU2054004C1 (ru) Производные 3(2н)-пиридазинона или их фармацевтически приемлемые соли и фармацевтическая композиция на их основе
US4990519A (en) Method of using quinolyloxazole-2-ones as proteinkinase C inhibitors
AU2021410119A9 (en) Tetrahydroquinoline derivative and medicinal use thereof
EP0164247B1 (fr) Dihydropyridines
US4677101A (en) Substituted dihydroazepines useful as calcium channel blockers
CA2214533C (fr) Quinolyloxazole-2-ones utiles comme inhibiteurs de la proteinekinase c
HUT64759A (en) Method for producing tetrazolyl-(phenoxy-and phenoxy-alkyl-)-pyridinyl-pyridazines
US4999431A (en) Process for preparing quinoline aldehyde and ketone derivatives
SG193461A1 (en) Azole derivative
EP1659112B1 (fr) Dérivés d'arylpipérazine comme ligands sélectifs du récepteur D3 de la dopamine
US5190957A (en) Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
JPS644518B2 (fr)
CA2021340C (fr) N-hydroxy-n-methylurease vinylogue cyclique utile en tant qu'inhibiteurs 5-lipoxidase
US4968680A (en) 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives, process for producing them and use thereof
CA2099630A1 (fr) Utilisation de phenoxyalkyl-piperidinylpyridazines heterocycliques comme agents antiviraux
KR0168645B1 (ko) 퀴놀릴옥사졸-2-온 및 이소퀴놀릴옥사졸-2-온의 다약제 내성 종양의 치료 용도
UA44249C2 (uk) 3-алкоксикарбонілтіадіазинони, спосіб їх одержання, фармацевтична композиція, спосіб одержання фармацевтичних композицій
EP0428106A1 (fr) Pyridyloxazolones-2 utiles comme inhibiteurs de la protéinekinase C
EP0946517A1 (fr) Derives de n-(imidazolylbutyle) benzenesulfonamide ayant une activite antithrombotique
CN118786119A (zh) 突变型idh1和idh2抑制剂及其应用
TAKEZAWA et al. Studies on Mesoionic Compounds. XIV. Synthesis of Mesoionic 1, 3-Thiazolium-4-thiolates
JPH02311479A (ja) キノリン誘導体

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20051017